Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ZYDUS LIFESCIENCES ABBOTT INDIA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 50.0 34.2 146.0% View Chart
P/BV x 18.2 5.8 315.2% View Chart
Dividend Yield % 1.2 0.6 202.1%  

Financials

 ABBOTT INDIA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
ZYDUS LIFESCIENCES
Mar-23
ABBOTT INDIA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs22,482495 4,542.2%   
Low Rs16,156319 5,058.2%   
Sales per share (Unadj.) Rs2,517.0170.3 1,478.0%  
Earnings per share (Unadj.) Rs446.819.8 2,259.0%  
Cash flow per share (Unadj.) Rs479.726.9 1,782.1%  
Dividends per share (Unadj.) Rs325.006.00 5,416.7%  
Avg Dividend yield %1.71.5 114.2%  
Book value per share (Unadj.) Rs1,480.5173.0 855.5%  
Shares outstanding (eoy) m21.251,012.20 2.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.72.4 321.0%   
Avg P/E ratio x43.220.6 210.0%  
P/CF ratio (eoy) x40.315.1 266.2%  
Price / Book Value ratio x13.02.4 554.6%  
Dividend payout %72.730.3 239.8%   
Avg Mkt Cap Rs m410,513412,144 99.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,63624,564 22.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,487172,374 31.0%  
Other income Rs m1,5434,746 32.5%   
Total revenues Rs m55,030177,120 31.1%   
Gross profit Rs m12,05529,677 40.6%  
Depreciation Rs m7007,227 9.7%   
Interest Rs m1601,299 12.3%   
Profit before tax Rs m12,73825,897 49.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,2445,878 55.2%   
Profit after tax Rs m9,49420,019 47.4%  
Gross profit margin %22.517.2 130.9%  
Effective tax rate %25.522.7 112.2%   
Net profit margin %17.811.6 152.8%  
BALANCE SHEET DATA
Current assets Rs m30,251100,082 30.2%   
Current liabilities Rs m12,06055,267 21.8%   
Net working cap to sales %34.026.0 130.8%  
Current ratio x2.51.8 138.5%  
Inventory Days Days8750 172.7%  
Debtors Days Days294 2.3%  
Net fixed assets Rs m15,135144,776 10.5%   
Share capital Rs m2131,012 21.0%   
"Free" reserves Rs m31,248174,146 17.9%   
Net worth Rs m31,460175,158 18.0%   
Long term debt Rs m00-   
Total assets Rs m45,386244,940 18.5%  
Interest coverage x80.720.9 385.3%   
Debt to equity ratio x00-  
Sales to assets ratio x1.20.7 167.5%   
Return on assets %21.38.7 244.4%  
Return on equity %30.211.4 264.0%  
Return on capital %41.015.5 264.1%  
Exports to sales %0.439.2 1.1%   
Imports to sales %10.811.9 90.4%   
Exports (fob) Rs m22167,577 0.3%   
Imports (cif) Rs m5,76520,544 28.1%   
Fx inflow Rs m31067,577 0.5%   
Fx outflow Rs m5,81820,544 28.3%   
Net fx Rs m-5,50847,033 -11.7%   
CASH FLOW
From Operations Rs m8,93426,888 33.2%  
From Investments Rs m-1,47711,712 -12.6%  
From Financial Activity Rs m-6,387-44,004 14.5%  
Net Cashflow Rs m1,070-5,338 -20.0%  

Share Holding

Indian Promoters % 0.0 75.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.9 18.0 49.5%  
FIIs % 0.2 5.0 3.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 100.0%  
Shareholders   72,252 306,495 23.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Abbott India vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs Cadila Healthcare Share Price Performance

Period Abbott India Cadila Healthcare S&P BSE HEALTHCARE
1-Day 0.74% 0.57% 1.18%
1-Month -5.97% 7.77% -0.75%
1-Year 24.80% 107.52% 61.82%
3-Year CAGR 21.40% 32.30% 18.16%
5-Year CAGR 29.91% 24.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of Abbott India, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.